Neonatal Abstinence Syndrome and Associated Health Care Expenditures United States, 2000-2009

Department of Pediatrics and Communicable Diseases, University of Michigan Health System, Ann Arbor, MI 48109-5604, USA.
JAMA The Journal of the American Medical Association (Impact Factor: 30.39). 04/2012; 307(18):1934-40. DOI: 10.1001/jama.2012.3951
Source: PubMed

ABSTRACT Neonatal abstinence syndrome (NAS) is a postnatal drug withdrawal syndrome primarily caused by maternal opiate use. No national estimates are available for the incidence of maternal opiate use at the time of delivery or NAS.
To determine the national incidence of NAS and antepartum maternal opiate use and to characterize trends in national health care expenditures associated with NAS between 2000 and 2009.
A retrospective, serial, cross-sectional analysis of a nationally representative sample of newborns with NAS. The Kids' Inpatient Database (KID) was used to identify newborns with NAS by International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) code. The Nationwide Inpatient Sample (NIS) was used to identify mothers using diagnosis related groups for vaginal and cesarean deliveries. Clinical conditions were identified using ICD-9-CM diagnosis codes. NAS and maternal opiate use were described as an annual frequency per 1000 hospital births. Missing hospital charges (<5% of cases) were estimated using multiple imputation. Trends in health care utilization outcomes over time were evaluated using variance-weighted regression. All hospital charges were adjusted for inflation to 2009 US dollars.
Incidence of NAS and maternal opiate use, and related hospital charges.
The separate years (2000, 2003, 2006, and 2009) of national discharge data included 2920 to 9674 unweighted discharges with NAS and 987 to 4563 unweighted discharges for mothers diagnosed with antepartum opiate use, within data sets including 784,191 to 1.1 million discharges for children (KID) and 816,554 to 879,910 discharges for all ages of delivering mothers (NIS). Between 2000 and 2009, the incidence of NAS among newborns increased from 1.20 (95% CI, 1.04-1.37) to 3.39 (95% CI, 3.12-3.67) per 1000 hospital births per year (P for trend < .001). Antepartum maternal opiate use also increased from 1.19 (95% CI, 1.01-1.35) to 5.63 (95% CI, 4.40-6.71) per 1000 hospital births per year (P for trend < .001). In 2009, newborns with NAS were more likely than all other hospital births to have low birthweight (19.1%; SE, 0.5%; vs 7.0%; SE, 0.2%), have respiratory complications (30.9%; SE, 0.7%; vs 8.9%; SE, 0.1%), and be covered by Medicaid (78.1%; SE, 0.8%; vs 45.5%; SE, 0.7%; all P < .001). Mean hospital charges for discharges with NAS increased from $39,400 (95% CI, $33,400-$45,400) in 2000 to $53,400 (95% CI, $49,000-$57,700) in 2009 (P for trend < .001). By 2009, 77.6% of charges for NAS were attributed to state Medicaid programs.
Between 2000 and 2009, a substantial increase in the incidence of NAS and maternal opiate use in the United States was observed, as well as hospital charges related to NAS.

Download full-text


Available from: Stephen W Patrick, Sep 25, 2014
1 Follower
  • Source
    • "2009 [15] [16] "
    [Show abstract] [Hide abstract]
    ABSTRACT: Objective. To identify factors associated with opioid use during pregnancy and to compare perinatal morbidity, mortality, and healthcare costs between opioid users and nonusers. Methods. We conducted a cross-sectional analysis of pregnancy-related discharges from 1998 to 2009 using the largest publicly available all-payer inpatient database in the United States. We scanned ICD-9-CM codes for opioid use and perinatal outcomes. Costs of care were estimated from hospital charges. Survey logistic regression was used to assess the association between maternal opioid use and each outcome; generalized linear modeling was used to compare hospitalization costs by opioid use status. Results.Women who used opioids during pregnancy experienced higher rates of depression, anxiety, and chronic medical conditions. After adjusting for confounders, opioid use was associated with increased odds of threatened preterm labor, early onset delivery, poor fetal growth, and stillbirth. Users were four times as likely to have a prolonged hospital stay and were almost four times more likely to die before discharge. The mean per-hospitalization cost of a woman who used opioids during pregnancy was $5,616 (95% CI: $5,166–$6,067), compared to $4,084 (95% CI: $4,002–$4,166) for nonusers. Conclusion. Opioid use during pregnancy is associated with adverse perinatal outcomes and increased healthcare costs.
    Journal of pregnancy 08/2014; 2014. DOI:10.1155/2014/906723
  • Source
    • "However, this study did not use a direct measure of self-control, rather measuring self-control using commitment to school and teacher influence. Research on prescription drug misuse is important given its high prevalence among young adults (Johnston et al., 2011b), the well-documented negative outcomes associated with the use and misuse of prescription drugs (Minino, Murphy, Xu, & Kochanek, 2011; Patrick et al., 2012; Substance Abuse and Mental Health Services Administration, 2010), and the lack of theoretically driven research. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Gottfredson and Hirschi's self-control theory has generated considerable academic interest and become one of the most influential theories of the past 20 years. The current study seeks to confirm and extend this line of research by examining the generality of self-control across several forms of substance use: binge drinking, marijuana use, prescription drug misuse, and other illicit drug use. Data were collected from a sample of more than 1,000 undergraduate students attending a public university in the United States. Findings indicate that students with low self-control were at greater risk for reporting binge drinking, marijuana use, and prescription drug misuse. Further analysis indicates that the influence of self-control on substance use is moderated by opportunity and peer influence. That is, self-control was significantly correlated to binge drinking and marijuana use when students reported greater opportunity to use and also when they reported substance use by their friends.
    Journal of drug issues 01/2013; 43(1):56-68. DOI:10.1177/0022042612462216 · 0.38 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Nurses have demonstrated concern for years about their interactions with pregnant women who abuse drugs. Reports of nurses' concern with substance abuse have been reported in the literature since the 1980s. As with any chronic disease, drug addiction causes physiologic changes, and the pathology that occurs in the brain drives characteristic behaviors. Research suggests that choices that addicts make are driven by pathology rather than by failure of a moral compass. This article reviews the theoretical explanations for addictive behaviors, describes the pathophysiology of drug addiction that is responsible for the predictable symptoms and behaviors exhibited by women who abuse prescription drugs and other opioids, and identifies nursing interventions to impact positive outcomes. Nurses who have a working knowledge of this disease will provide more effective nursing care to the women they encounter and are better prepared to make a difference in the lives of both women and their children.
    Neonatal network: NN 01/2014; 33(1):11-8. DOI:10.1891/0730-0832.33.1.11
Show more